They offer a range of services including spatial biology, liquid biopsy, proteomics, genomics, and biomarker discovery and validation. Their team of certified professionals, including MD pathologists and PhD scientists, ensures effective communication and a deep understanding of clients' requirements. iCura Diagnostics specializes in histology, multiplex IHC/IF, immune-therapy, cell and gene therapy, tumor microenvironment, organoid culture systems, and other crucial areas for drug discovery, translational research, and clinical diagnosis.

Their state-of-the-art technology guarantees unmatched accuracy, efficient turnaround times, and advanced analytics. With CLIA high complexity certification and CAP accreditation, iCura Diagnostics upholds the highest standards of quality control and regulatory compliance. Partnering with them assures precise, reliable, and compliant research solutions.

They are committed to transforming clinical trials and medical diagnoses, offering FDA-approved circulating tumor cell services and advanced next-generation sequencing platforms